Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis

Neurologic Clinics(2023)10.1016/j.ncl.2023.06.004Source: DataRank Database

Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis is a research paper published in Neurologic Clinics (2023). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

19 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 3.34)OA: closedTopics (26)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Ellen M. Mowry ORCID,Daniel Ontaneda ORCID,Alise Carlson ORCID,Nicole Bou Rjeily ORCID

Live enrichment

PubMed:37980115 OpenAlex:https://openalex.org/W4386034143

Biogen

Grant: ICT-1805-31154

FWCI

3.34

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S0733861923000567?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0733861923000567?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ncl.2023.06.004

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37980115

Fields of Study

Multiple Sclerosis Research StudiesRheumatoid Arthritis Research and TherapiesViral Infections and Immunology ResearchHumansMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingTreatment OutcomeDisease Progression

MeSH Terms

HumansMultiple SclerosisTreatment OutcomeDisease ProgressionMultiple Sclerosis, Relapsing-Remitting

Keywords

MedicineIntensive care medicineMultiple sclerosisRandomized controlled trialClinical trialDiseaseDe-escalationInternal medicinePsychiatryDisease-modifying therapyEary highly effective therapyEscalation therapyRelapsing-remitting multiple sclerosis

Sustainable Development Goals

SDG 0: Good health and well-being

Related Papers (1)

Rating neurologic impairment in multiple sclerosis

N/A

1.4DataRank · unranked

Neurology(1983)

co-cited

10.1212/wnl.33.11.1444

Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis

FAIR Checklist

Authors (4)

Funding (1 grants)

Impact

Open Access

Topics

Related Papers (1)